(July 2021)
“These findings are relevant for physicians, highlighting the need for regular reassessment of ongoing treatments,” the authors note. “This is especially important in patients prescribed long-term PPIs and for patients without an evidence-based indication for use,” they conclude.
👨🏻⚕️ About the text in the link, its conclusion and what I explain about IBPs in https://icaro.med.br/prazol/ (I suggest you go there), I emphasize:
1️⃣ Medicines may be necessary and helpful, especially for a short period of time, but it is worrying when they cause what they were developed to prevent or protect against;
2️⃣ Almost 70% of people who use IBPs, especially for more than a few months, they wouldn't need to use them. I explain how and why in the link above on my website.
3️⃣ Do you really want to optimize the health of your stomach and intestines? The basics are explained here: https://icaro.med.br/saudeintestinal/
4️⃣ The greatest proof that PPIs were not originally designed for prolonged or chronic use is that it can cause or aggravate a multitude of unpleasant effects.
5️⃣ In my office, almost every week I see patients who have been prescribed drugs that, in my opinion, shouldn't have been prescribed, shouldn't have been used for so long or are already leading to more bad effects than good. This is largely because those who use them haven't properly optimized the basics: healthy lifestyle habits - explained in https://icaro.med.br/en/15habits/.
☀️ Have a good weekend and God speed!
Source: UNIVADIS (from Medscape) by Heather Mason on July 13, 2021
Português do Brasil 
English 